Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Scandic Hotels Group AB (publ) on an offering of convertible bonds and an extension of the existing credit facilities
Mandate

Vinge has advised Scandic Hotels Group AB (publ) on an offering of convertible bonds and an extension of the existing credit facilities

April 26, 2021 Banking and Finance Capital Markets and Public M&A

Vinge has advised Scandic Hotels Group AB (publ) on an offering of convertible bonds raising approximately SEK 1,609 million in gross proceeds and an extension of the existing SEK 6,650m credit facilities.

Scandic is the largest hotel company in the Nordic countries with about 58,000 rooms at approximately 280 hotels in operation and under development. Scandic is listed on Nasdaq Stockholm, Mid cap.

Vinge’s team primarily consisted of Jesper Schönbeck, Amanda Knutsson, William Kåge and Anders Sundin Lundberg (Capital markets), Louise Brorsson Salomon, Linn Adelwald, Ludvig Wettergren and Rebecka Målquist (Banking and Finance).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026